[基于CRISPR/Cas9技术的毒素菌疫苗研究进展]
1Shandong Institute of Parasitic Diseases, Shandong First Medical University & Shandong Academy of Medical Sciences, Jining, Shandong 272033, China.
概括
这篇评论探讨了CRISPR/Cas9基因编辑用于开发针对Toxoplasma gondii的疫苗,Toxoplasma gondii是一种导致人类和动物中毒素的寄生虫. 它强调了为有效的疫苗开发创造单基因和双基因删除菌株的应用.
科学领域:
- 寄生虫学的寄生虫学
- 分子生物学分子生物学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 毒素菌是一种有义务的细胞内寄生虫,负责毒素菌,对人类健康和动物农业构成重大威胁.
- 有效的疫苗对于控制毒素菌至关重要.
- 基因编辑技术为疫苗开发提供了有前途的途径.
研究的目的:
- 审查CRISPR/Cas9技术在开发针对Toxoplasma gondii的疫苗中的应用.
- 总结一下CRISPR/Cas9用于制造T. gondii的单基因和双基因删除菌株,用于疫苗研究.
- 为未来开发毒素菌疫苗提供洞察力.
主要方法:
- 在T. gondii研究中使用CRISPR/Cas9的研究的文献综述.
- 分析CRISPR/Cas9的应用,以产生基因被删除的T. gondii菌株.
- 综合与疫苗开发策略相关的发现.
主要成果:
- 克里斯普尔/卡斯9是一种强大的工具,用于针对性基因淘汰T. gondii.
- 克里斯普尔/Cas9促进了单基因和双基因删除突变的产生.
- 这些工程菌株显示出针对毒素菌的疫苗开发潜力.
结论:
- 克里斯普尔/Cas9技术在推动T. gondii疫苗的开发方面发挥了重要作用.
- 基因编辑方法为制造减弱或亚单元疫苗提供了新的策略.
- 进一步利用CRISPR/Cas9的研究将加速制造有效的毒素菌疫苗.
更多相关视频
09:49Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
Published on: April 29, 2020
7.1K
09:25CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum
Published on: September 18, 2018
9.9K
相关概念视频
CRISPR
49.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.4K
CRISPR and crRNAs
16.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.7K
